Azioni Innovus Pharmaceuticals Inc Other OTC
Azioni
US45778V1061
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Variaz. 1 gen. | Capi. | |
---|---|---|
+33,97% | 693 Mrd | |
+29,39% | 584 Mrd | |
-2,87% | 372 Mrd | |
+20,57% | 332 Mrd | |
+6,96% | 294 Mrd | |
+14,09% | 239 Mrd | |
-3,03% | 211 Mrd | |
+10,02% | 210 Mrd | |
+9,13% | 168 Mrd |